Litigation Details for SENJU PHARMACEUTICAL CO., LTD v. INNOPHARMA LICENSING, INC. (D.N.J. 2016)
✉ Email this page to a colleague
SENJU PHARMACEUTICAL CO., LTD v. INNOPHARMA LICENSING, INC. (D.N.J. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-03-10 |
Court | District Court, D. New Jersey | Date Terminated | 2016-10-13 |
Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
Jury Demand | None | Referred To | Karen M. Williams |
Parties | INNOPHARMA LICENSING, INC. | ||
Patents | 8,129,431; 8,669,290; 8,754,131; 8,871,813; 8,927,606; 9,144,609 | ||
Attorneys | KATHERINE ANN ESCANLAR | ||
Firms | Pepper Hamilton LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SENJU PHARMACEUTICAL CO., LTD v. INNOPHARMA LICENSING, INC.
Details for SENJU PHARMACEUTICAL CO., LTD v. INNOPHARMA LICENSING, INC. (D.N.J. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2016-10-13 | 23 | ’ U.S. Patent No. 8,129,431 (“the ‘431 patent”), U.S. Patent No. 8,669,290 (“the ‘290 patent”), U.S.…U.S. Patent No. 8,754,131 (“the ‘131 patent”), U.S. Patent No. 8,871,813 (“the ‘813 patent”), U.S. Patent…,927,606 (“the ‘606 patent”), and U.S. Patent No. 9,144,609 (“the ‘609 patent”) asserted against Defendants…, ‘131, ‘813, ‘606 and ‘609 patents in any future litigation, patent office proceeding, or otherwise…Plaintiffs, the ‘431, ‘290, ‘131, ‘813, ‘606, and ‘609 patents are valid, enforceable, and would be infringed | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |